SUMATRIPTAN SUCCINATE
| Brand name | ZEMBRACE SYMTOUCH |
|---|---|
| Active ingredient | SUMATRIPTAN SUCCINATE |
| Strength | EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML) |
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | January 2016 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10537554 | January 2036 | use U-72 |
| 11364224 | January 2036 | use U-72 |
| 12097183 | January 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.